LENZ Therapeutics Stock Quote LENZ - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

18.06

Bid

15.00

Ask

23.87

Volume

240,161

17.84 Day's Range 18.75

14.42 52 Week Range 24.59

Market Cap

459.876M

Previous Close

18.32

Open

18.38

Last Trade

Last Trade Time

Financial Volume

$ 4,362,984

VWAP

18.1669

Average Volume (3m)

157,524

Shares Outstanding

25,534,458

Dividend Yield

PE Ratio

-3.69

Earnings Per Share (EPS)

-4.88

Revenue

Net Profit

-124.65M

Graphite Bio Inc is a clinical-stage gene-editing company harnessing gene integration to develop a new class of therapies to cure serious and life-threatening diseases. Its gene-editing platform allows to precisely correct mutations, replace entire disease-causing genes with normal genes, or insert ... Graphite Bio Inc is a clinical-stage gene-editing company harnessing gene integration to develop a new class of therapies to cure serious and life-threatening diseases. Its gene-editing platform allows to precisely correct mutations, replace entire disease-causing genes with normal genes, or insert new genes into predetermined, safe locations. Its lead product candidate GPH101 is a differentiated approach with the potential to directly correct the mutation that causes sickle cell disease (SCD) and restore normal adult hemoglobin (HgbA) expression. All of the company's long-lived assets are based in the United States. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.lenz-tx.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

LENZ Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker LENZ. The last closing price for LENZ Therapeutics was $18.32. Over the last year, LENZ Therapeutics shares have traded in a share price range of $ 14.42 to $ 24.59.

LENZ Therapeutics currently has 25,534,458 shares outstanding. The market capitalization of LENZ Therapeutics is $459.88 million. LENZ Therapeutics has a price to earnings ratio (PE ratio) of -3.69.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.42	2.38095238095	17.64	19.48	17.64	173063	18.47641938	CS
4	-0.23	-1.25751776927	18.29	19.98	14.42	179742	16.66494874	CS
12	-3.09	-14.609929078	21.15	24.59	14.42	157524	17.16100707	CS
26	2.08	13.0162703379	15.98	24.59	14.42	158436	17.29811787	CS
52	2.08	13.0162703379	15.98	24.59	14.42	158436	17.29811787	CS
156	2.08	13.0162703379	15.98	24.59	14.42	158436	17.29811787	CS
260	2.08	13.0162703379	15.98	24.59	14.42	158436	17.29811787	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
GRDIGRIID Infrastructure Inc	$ 1.11 (98.21%)	155.65M
ZAPPZapp Electric Vehicles Group Ltd	$ 2.33 (71.32%)	91.49M
MGOLMGO Global Inc	$ 0.725 (58.16%)	160.27M
RELIReliance Global Group Inc	$ 0.61 (55.97%)	139.38M
HAOHaoxi Health Technology Ltd	$ 6.36 (38.26%)	693.26k
WHLRWheeler Real Estate Investment Trust Inc	$ 2.75 (-82.51%)	164.01k
KAVLKaival Brands Innovations Group Inc	$ 2.90 (-35.56%)	1.31M
MBIOMustang Bio Inc	$ 0.5605 (-34.07%)	38.18M
SONNSonnet BioTherapeutics Holdings Inc	$ 1.04 (-32.03%)	432.19k
NKLANikola Corporation	$ 0.3279 (-31.82%)	269.83M
NVDANVIDIA Corporation	$ 130.78 (-3.54%)	518.09M
NKLANikola Corporation	$ 0.3279 (-31.82%)	269.83M
SMXSMX Security Matters Public Company	$ 0.16 (34.45%)	177.78M
SQQQProShares UltraPro Short QQQ	$ 8.32 (2.46%)	166.97M
MGOLMGO Global Inc	$ 0.725 (58.16%)	160.27M